Trials / Completed
CompletedNCT06594185
A Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract Extraction
A Prospective, Multicenter, Open Label, Single Arm, Post-Marketing Clinical Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract Extraction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 335 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
A study to evaluate the real-world clinical performance of the enVista Aspire and Aspire Toric intraocular lens (IOL) models EA and ETA and to assess surgeon and subject satisfaction
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | enVista Aspire EA or Aspire Toric ETA IOLs | enVista Aspire EA or Aspire Toric ETA IOLs |
Timeline
- Start date
- 2024-08-29
- Primary completion
- 2025-05-21
- Completion
- 2025-05-21
- First posted
- 2024-09-19
- Last updated
- 2025-07-10
Locations
62 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06594185. Inclusion in this directory is not an endorsement.